In conclusion, our studies propose for the first time that c-Met plays a role in TRAIL-resistance of brain tumors by interacting with DR5 (without changing DR5 levels) and affecting DISC formation and subsequently TRAIL-mediated apoptosis execution both in vitro and in vivo. Here, TNFRSF10B is linked to brain neoplasm.